This company is no longer active
Gemini Therapeutics Future Growth
How is Gemini Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
|Date||Revenue||Earnings||Free Cash Flow||Cash from Op||Avg. No. Analysts|
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GMTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GMTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GMTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if GMTX's revenue is forecast to grow faster than the US market.
High Growth Revenue: GMTX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GMTX's Return on Equity is forecast to be high in 3 years time